Radiopharm Theranostics Ltd (RAD) — Net Asset Momentum
Radiopharm Theranostics Ltd (RAD) recorded a net asset momentum of -47.9% as of June 2026, with net assets of AU$22.32 Million AUD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See RAD book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Radiopharm Theranostics Ltd Net Asset Momentum (2021–2026)
This chart tracks Radiopharm Theranostics Ltd's year-over-year net asset growth across 6 annual reporting periods from 2021 to 2026. The most recent momentum reading is -47.9%, with net assets of AU$22.32 Million AUD as of June 2026. For live market cap and overall valuation, see Radiopharm Theranostics Ltd market capitalisation.
Annual Net Asset History for Radiopharm Theranostics Ltd (2021–2026)
The table below shows the complete annual net asset history for Radiopharm Theranostics Ltd from 2021 to 2026, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check RAD goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (AUD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | AU$22.32 Million | AU$60.13 Million | AU$37.81 Million | ▼ -47.9% |
| 2025 | AU$42.87 Million | AU$86.48 Million | AU$43.61 Million | ▲ +56.7% |
| 2024 | AU$27.35 Million | AU$72.04 Million | AU$44.68 Million | ▼ -40.0% |
| 2023 | AU$45.58 Million | AU$74.95 Million | AU$29.37 Million | ▼ -27.6% |
| 2022 | AU$62.96 Million | AU$83.38 Million | AU$20.42 Million | ▲ +50590.1% |
| 2021 | AU$-124.70K | AU$33.44K | AU$158.14K | — |